The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain
NCT: NCT05741788 · RECRUITING
Brief Summary
Spinal cord stimulation modulates the nervous system to effectively block pain signals originating from the back and legs. Spinal cord stimulation has been shown to improve chronic pain, improve quality of life, and reduce disability. Unfortunately, spinal cord stimulation has a high trial failure rate and a high long-term failure rate. This study consists of a prospective cohort of patients clinically scheduled to undergo spinal cord stimulation for the treatment of chronic back pain or radiculopathy. Participants will undergo a structured optimization evaluating existing types of stimulation (tonic, burst, and multistim). Each participant will try out all types of available stimulation but be blinded to the type. Over the course of four months, each participant will evaluate each type of stimulation by reporting daily pain scores. Thompson sampling will be used to identify which setting produces the biggest improvement in pain and recommend it for future use. Participants will follow up routinely to collect laboratory, behavioral, and survey responses to test for the feasibility of obtaining data explaining pain phenotype.
Frequently Asked Questions
What is The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain?
The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain is a clinical trial registered under NCT05741788. Current status: RECRUITING.
What is the status of NCT05741788?
The current status of NCT05741788 (The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain) is: RECRUITING.
When did The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain start?
The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain started on 2023-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.